Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0001 USD
Change Today 0.00 / 0.00%
Volume 0.0
AKLPF On Other Exchanges
As of 4:30 PM 06/27/15 All times are local (Market data is delayed by at least 15 minutes).

akela pharma inc (AKLPF) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AKELA PHARMA INC (AKLPF)

Related News

No related news articles were found.

akela pharma inc (AKLPF) Related Businessweek News

No Related Businessweek News Found

akela pharma inc (AKLPF) Details

Akela Pharma, Inc. operates as a specialty contract pharmaceutical formulation developer in the United States. It offers contract pharma services comprising formulation and process development of drug in tablets, capsules, multiparticulates, fast formulations, oral and topical liquids, powders for suspension/reconstitution, and semi-solid forms. The company also provides analytical services, which include research and development analytical testing and support for formulation development; analytical method development and phase-appropriate validation; quality control testing for API and raw materials release; and stability testing and ICH compliant stability storage. In addition, it offers drug delivery solutions, such as hot melt extrusion for amorphous dispersions, spray-drying for amorphous dispersions, controlled release dosage forms, liquid solutions (encapsulated and bottled), and novel dosage forms, as well as beads, granulation, and drug layering services. Further, the company’s contract services consist of handling of potent compounds; pharmaceutical patent litigation support services; GMP clinical and commercial manufacturing; clinical labeling and packaging; and IP validation and contestation consulting services. The company was formerly known as LAB International Inc. and changed its name to Akela Pharma, Inc. in June 2007. Akela Pharma, Inc. was founded in 1979 and is headquartered in Austin, Texas.

57 Employees
Last Reported Date: 03/30/12
Founded in 1979

akela pharma inc (AKLPF) Top Compensated Officers

Principal Financial Officer
Total Annual Compensation: --
President of LAB Pre-Clinical Research Inc
Total Annual Compensation: --
Executive Vice President and Corporate Secret...
Total Annual Compensation: --
Chief Scientific Officer of LAB Pharma
Total Annual Compensation: --
Chief Operating Officer of Pre Clinical
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AKLPF:US $0.00 USD 0.00

AKLPF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AKLPF.
View Industry Companies

Industry Analysis


Industry Average

Valuation AKLPF Industry Range
Price/Earnings 0.0x
Price/Sales 0.0x
Price/Book NM Not Meaningful
Price/Cash Flow 0.0x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AKELA PHARMA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at